Related Experiment Videos
Vasoactive intestinal peptide gene expression from embryos to aging rats
I Gozes1, P Schächter, Y Shani
1Department of Hormone Research, Weizmann Institute of Science, Rehovot, Israel.
Neuroendocrinology
|January 1, 1988
Summary
Vasoactive intestinal peptide (VIP) gene expression is high during embryonic development in rats. VIP mRNA levels significantly decrease in aging rats, suggesting a role in development and age-related neuronal changes.
Area of Science:
- Neuroscience
- Molecular Biology
- Developmental Biology
Background:
- Vasoactive intestinal peptide (VIP) is a neuropeptide with diverse physiological roles.
- Understanding VIP gene expression patterns is crucial for insights into neural development and aging.
Purpose of the Study:
- To investigate the expression levels of vasoactive intestinal peptide (VIP) gene transcripts during rat embryonal development and aging.
- To explore the potential implications of VIP gene expression changes in neurodevelopment and aging processes.
Main Methods:
- RNA blot hybridization was employed to detect and quantify VIP gene transcripts.
- VIP-specific RNA probes were utilized for accurate transcript detection.
- Expression levels were compared between embryonic (16-day-old), young adult (21-day-old), and aging rats.
Main Results:
- High levels of vasoactive intestinal peptide (VIP) gene transcripts were detected as early as in 16-day-old rat embryos.
- Significant reductions in VIP mRNA levels were observed in the cerebral cortex of aging rats compared to 21-day-old rats.
- These findings indicate dynamic changes in VIP gene expression throughout the lifespan.
Conclusions:
- The VIP gene and its protein products likely play a significant role during embryonal neural development.
- The observed decrease in VIP gene transcripts during aging may result from reduced transcriptional activity in VIP neurons or cell death.
- These age-related changes in VIP expression may contribute to functional alterations in the aging brain.